External beam pituitary irradiation has been frequently used in the treatment of growth hormone (GH) secreting pituitary adenomas. Many studies have demonstrated that serum GH declines rapidly and reliably following treatment and early “cure” rates, based on a basal serum GH below 10 µg/L were as high as 80%. The definition of “cure” has become more stringent over time and retrospective studies have indicated that GH must be below 2.5 µg/L for acromegalics to achieve mortality rates comparable to a normal population. Only 20% of irradiated patients will achieve this goal by 10 yr. Even fewer will achieve a normal serum insulin-like growth factor I (IGF-I) levels. Although pituitary irradiation still has a role in the control of tumor size, its importance as a treatment for normalizing serum GH is being reevaluated.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Clayton RN. New developments in the management of acromegaly. Should we achieve absolute biochemical cure. J Endocrinol 1997;155: S23-S29.
Laws ER, Piepgras DG, Randall RV, Abboud CF. Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977. J Neurosurg 1979;50: 454–461.
Jaffe CA, Barkan AL. Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am 1992;21:713–735.
Fahlbusch R, Honegger J, Buchfelder M. Evidence supporting surgery as treatment of choice for acromegaly. J Endo-crinol 1997;155:S53–55.
Jenkins D, O'Brien I, Johnson A, Shakespear R, Sheppard MC, Stewart PM. The Birmingham pituitary database: Auditing the outcome of the treatment of acromegaly. Clin Endocrinol 1995;517–522.
Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med1993;86: 293–299.
Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 1994;41:95–102.
Wrightson P, Rajasoorya C, Holdaway M Scott J. Acromegaly: Factors affecting the long-term outcome after surgical treatment. J Clin Neurosci 1994;1:164–172.
Jaffe CA, Turgeon DK, DeMott Friberg R, Watkins PB, Barkan AL.Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: Potential involvement of endogenous somatostatin. J Clin Endocrinol Metabol 1995; 80:3321–3326.
Jaffe CA, Ocampo-Lim BN, Krueger K, Sugahara I, Mauger DT, DeMott-Friberg R, Barkan AL. Sexual dimorphism of growth hormone secretion and regulation in humans. J Clin Invest 1998;102:153–164.
Chang-DeMoranville BM, Jackson IMD. Diagnosis and endocrine testing in acromegaly. Endocrinol Metab Clin North Am 1992;21:649–668.
Chapman IM, Hartman M, Straume M, Johnson ML, Veldhuis JD, Thorner MO. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 1994;78:1312–1319.
Barkan AL, Beitins IZ, Kelch RP. Plasma insulin-like growth factor-I/somatomedin-c in acromegaly: Correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 1988;67:69–73.
Daughaday WH, Starkey RH, Saltman S, Gavin III JR, Mills-Dunlop B, Health-Monnig E. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. J Clin Endocrinol Metab 1987;65–617–623.
Brockmeier SJ, Buchfelder M, Adams EF, Schott W, Fahlbusch R. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery. Horm Metabol Res 1992;24: 392–400.
Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, DeMott Friberg R, Chandler WF, et al. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 1997;82:3187–3191.
Spagnoli A, Rosenfeld RG. The mechanisms by which growth hormone brings about growth. Endocrinol Metab Clin North Am 1996;25:615–631.
Eastman TC, Gorden P, Glatstein E, Roth J. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am 1992;21:693–712.
Halberg FE, Sheline GE. Radiotherapy of pituitary tumors. Endocrinol Metab Clin North Am 1987;16:667–684.
Feek CM, McLelland J, Seth J, Toft AD, Irvine WJ, Padfield PL, Edwards CR. How effective is external pituitary irra-diation for growth hormone-secreting pituitary tumors? Clin Endocrinol 1984;20:401–408.
Goffman TE, Dewan R, Arakaki R, Gorden P, Oldfield EH, Glatstein E. Persistent or recurrent acromegaly. Long-term endocrinologic efficacy and neurologic safety of postsurgical radiation therapy. Cancer 1992;69:271–275.
Speirs CJ, Reed PI, Morrison R, Aber V, Joplin GF. The effectiveness of external beam radiotherapy for acromegaly is not affected by previous pituitary ablative treatments. Acta Endocrinol (Copenh) 1990;122:559–565.
Sheline GF. Conventional radiation therapy in the treatment of pituitary tumors. In [Editor(s)?]. Clinical Management of Pituitary Disorders New York: Raven Press, 1979;287.
Werner S, Af Trampe E, Palacios P, Lax I, Hall K. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation. Int J Radiant Oncol Biol Phys 1985;11: 1713–1720.
Wass JA, Moult PJ, Thorner MO, Dacie JE, Charlesworth M, Jones AE, Besser GM. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet 1979; 2(8133):66–69.
Littley MD, Shalet SM, Swindell, Beardwell CG, Sutton ML. Low-dose pituitary irradiation for acromegaly. Clin Endocrinol 1990;32:261–270.
Baldwin A, Cundy T, Butler J, et al. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Act Endocrinol (Copenh) 1985;108: 26–30.
Eastman RC, Gorden P, Roth J. Conventional supervoltage irradiation is an effective treatment for acromegaly. J Clin Endocrinol Metab 1979;48:931–940.
Lombardi G, Colao A, Marzullo P, Ferone D, Longobardi S, Esposito V, Merola B. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. J Endocrinol 1997;155:S33-S37.
MacSweeney JE, Baxter MA, Joplin GF. Heel pad thickness is an insensitive index of biochemical remission in acromegaly. Clin Radiol 1990;42:348–350.
Colao A, Marzullo P, Vallone G, et al. Reversibility of joint thickening in acromegalic patients; an ultrasonography study. J Clin Endocrinol Metab 1998;83:212–215.
Jaffe CA, Barkan AL. Acromegaly: Recognition and drug treatment. Drugs 1994;47:425–445.
Ciccarelli E, Valett MR, Vasario E, Avateneo T, Grottoli S, Camanni F. Hormonal and radiologic effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Endocrinol Invest 1993;16:565–572.
af Traupe E, Lundell G, Lax I, Werner S. External irradiation of growth hormone producing pituitary adenomas: Prolactin as a marker of hypothalamic and pituitary effects. Int J Radiat Oncol Biol Phys 1991;20:655–660.
Thalassinos NC, Tsagarakis S, Ioannides G, Tzavara I, Papavasiliou C. Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: A long term follow-up study. Eur J Endocrinol 1998;138:160–163.
Lucas T, Brito M, Estrada J, Alcaniz A, Magallon R, G-Uria J, Barcelo B. Conventional radiotherapy in the treatment of acromegaly: Is it a choice? Program of the Fifth International Pituitary Congress; June 28–30, 1998; Naples, FL;33.
Ludecke DK, Lutz BS, Niedworok G. The choice of treatment after incomplete adenomectomy in acromegaly: Proton versus highvoltage radiation. Act Neurochir 1989;96:32–38.
Thoren M, Rahn T, Guo WY, Werner S. Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumors. Neurosurgery 1991;29:663–668.
Vance ML, Woodburn J, Steiner L, Laws ER. Gamma knife radiation for functinal pituitary adenomas. In 80th Annual Meeting of the Endocrine Society, New Orleans, LA, 1998; 400.
Howatt TA, Plowman PN, Wass JA, Rees LH, Jones AE, Besser GM. Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: Long term follow-up. Clin Endocrinol 1989;31:309–323.
Orth DN, Liddle GW. Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med 1971;285:243–247.
Estrada J, Boronat M, Mielgo M, et al. The long-term out-come of pituitary irradiation after unsuccessful transsphe-noidal surgery in Cushing's disease. N Engl J Med 1997; 336:172–177.
Tsagarakis S, Grossman A, Plowman PN, et al. Megavoltage pituitary irradiation in the management of prolactinomas: Long-term follow-up. Clin Endocrinol 1991;34:399–406.
Tsang RW, Brierley JD, Panzarell T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ. Role of radiation therapy in clinically hormonally-active pituitary adenomas. Radioth Oncol 1996;41:45–53.
Snyder PJ, Fowbel BF, Schatz NJ, et al. Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 1986;81:457–462.
Macleod AF, Clarke DG, Pambakian H, Lowy C, Sonksen PH, Collins CD. Treatment of acromegaly by external irra-diation. Clin Endocrinol 1989;30:303–314.
Littley MD, Shalet SM, Swindell R, Beardwell CG, Sutton ML. Low-dose pituitary irradiation for acromegaly. Clin Endocrinol 1990;32:261–270.
Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M. External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 1995;33:307–314.
Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol 1989;31:363–373.
Millar JL, Spry NA, Lamb DS, Delahunt J. Blindness in patients after external beam irradiation for pituitary ade-nomas: two cases occurring after small daily fractional doses. Clin Oncol 1991;3:291–294.
al-Mefty O, Kersh JE, Routh A, Smith RR. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990;73:502–512.
Grattan-Smith PJ, Morris JG, Langlands AO. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours. J Neurol Neurosurg Psych 1992;55:949–955.
Thajeb P. Progressive late delayed postirradiation encephalopathy with Kluver-Bucy syndrome. Serial MRI and clinicopathologic studies. Clin Neurol Neurosurg 1995;97:264–268.
Kleinschmidt-DeMaters BK. Necrotizing brainstem leukoencephalopathy six weeks following radiotherapy. Clin Neuropath 1995;14:63–68.
Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980;6:1215–1218.
Bliss P, Kerr GR, Gregor A. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962–1990. Clin Oncol 1994;6:361–363.
Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin Endocrinol 1991;3579–397.
Tsang RW, Lapperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 1993;72:2227–2233.
Brada M, Ford D, Ashley S, Mason M, Bliss J, Traish D, Rajon B, Proley S. Risk of second brain tumour following conservative surgery and radiotherapy of pituitary adenoma. B Med J 1992;304:1343–1346.
Simmons NE, Laws ER Jr. Gioma occurrence after sellar irradiation: case report and review. Neurosurgery 1998;42: 172–178.
Partington MD, Davis DH. Radiation-induced meningioma after treatment for pituitary adenoma: case report and literature review. Neurosurgery 1990;26:329–331.
Suda Y, Mineura K, Kowada M, Ohishi H. Malignant astrocytoma following radiotherapy in pituitary adenoma: Case report. No Shinkei Geka Neurol Surg 1989;17:783–788.
Liuzzi A, Oppizzi G. Evidence for octreotide subcutaneously in the treatment of acromegaly. J Endocrinol 1997;155: S61-S65.
About this article
Cite this article
Jaffe, C.A. Reevaluation of Conventional Pituitary Irradiation in the Therapy of Acromegaly. Pituitary 2, 55–62 (1999). https://doi.org/10.1023/A:1009969921497
- growth hormone
- anterior pituitary
- insulin-like growth factor I